Company / Operating Cash Flow per Share
AVADEL PHARMACEUTICALS PLC Operating Cash Flow per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.49
FY2024
5-year range
-$1.60 / -$0.49
FY2020-FY2024
Trend
+69.2%
vs FY2023
Sector context
#103 of 212
Health Care
What the data says
At $-0.49, AVADEL PHARMACEUTICALS PLC's operating cash flow per share ranks #103 of 212 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-2.22 in FY2018 to $1.93 in FY2015.
Based on SEC 10-K filings.
-0.49 in FY2024.
Improved from $-1.17 to $-0.49 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#103 of 212 in Health CareTop 49% of 212This company -$0.49 Sector average -$14.72
▼
+96.7% above sector average
Key checks
Key Insights
- In FY2024, operating cash flow per share increased 69.2% year-over-year.
- Ranks #103 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2015.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.49 | +69.2% |
| FY2023 | -$1.60 | -37.0% |
| FY2022 | -$1.17 | +11.4% |
| FY2021 | -$1.32 | -48.9% |
| FY2020 | -$0.89 | +13.4% |
| FY2019 | -$1.02 | +53.8% |
| FY2018 | -$2.22 | -655.5% |
| FY2017 | $0.40 | -12.9% |
| FY2016 | $0.46 | -76.3% |
| FY2015 | $1.93 | +759.2% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026